Join the Osteoarthritis group to help and get support from people like you.
Osteoarthritis News (Page 3)
Related terms: Arthritis, Osteoarthritis, Degenerative Arthritis, Degenerative joint disease (DJD), Hypertrophic Osteoarthritis, Osteoarthrosis, DJD, OA, Degenerative Joint disease, Joint Pain, Gonarthrosis, Sacroiliac Arthritis
Using Meds to Manage Your Arthritis Pain: An Overview
TUESDAY, Sept. 19, 2023 – Millions of Americans suffer from arthritis, and many reach for medication to ease their joint pain and inflammation. The options might seem overwhelming, though. Here, the...
Use of Nonselective β-Blockers Tied to Lower Risk for Total Knee Arthroplasty
FRIDAY, Sept. 15, 2023 – The use of nonselective β-blockers is associated with a lower likelihood of undergoing total knee arthroplasty (TKA), according to a study published online Sept. 5 in the ...
Total Hip Arthroplasty Can Be Performed Safely in 90-Year-Olds
THURSDAY, Aug. 31, 2023 – While 90-year-olds undergoing elective total hip arthroplasty (THA) have higher complication and mortality rates than younger patients undergoing THA, their mortality rates...
Space Travel Takes Toll on Astronauts' Blood, Bone
WEDNESDAY, Aug. 23, 2023 – When astronauts travel to space, the experience depletes their red blood cells and bone, according to a new study. Fortunately, it appears their bodies can eventually...
1 Billion People Worldwide Will Suffer From Arthritis by 2050
TUESDAY, Aug. 22, 2023 – The degenerative joint disease osteoarthritis affects 15% of the global population over age 30, so by 2050 that could be nearly 1 billion people, researchers say. Living...
7.6 Percent of Global Population Had Osteoarthritis in 2020
TUESDAY, Aug. 22, 2023 – The global burden of osteoarthritis has increased since 1990 and is projected to continue increasing, according to a study published online Aug. 21 in The Lancet...
FDA Approves Consensi (amlodipine and celecoxib) for Treatment of Hypertension and Osteoarthritis Pain
TEL AVIV, Israel, May 31, 2018 (GLOBE NEWSWIRE) – Kitov Pharma Ltd. (NASDAQ: KTOV; TASE: KTOV), an innovative biopharmaceutical company, announced today that the U.S. Food and Drug Administration...
FDA Medwatch Alert: Limbrel Capsules by Primus Pharmaceuticals: FDA Advisory - Linked to Potentially Life-Threatening Health Problems
ISSUE: The U.S. Food and Drug Administration is investigating serious adverse events involving Limbrel, a product in capsule form currently being marketed as a medical food to manage the metabolic...
Flexion Therapeutics Announces FDA Approval of Zilretta (triamcinolone acetonide extended-release injectable suspension) for Osteoarthritis Knee Pain
BURLINGTON, Mass., Oct. 06, 2017 (GLOBE NEWSWIRE) – Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that the U.S. Food and Drug Administration (FDA) approved Zilretta (triamcinolone...
FDA Approves Vivlodex (meloxicam) for Osteoarthritis Pain
PHILADELPHIA, October 23, 2015 — Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that the United States Food and ...
Iroko Pharmaceuticals Gains FDA Approval of Zorvolex for Management of Osteoarthritis Pain
PHILADELPHIA, August 25, 2014 — Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today the United States Food and Drug A...
FDA Medwatch Alert: Super Arthgold by Nano Well-being Health: Recall - Undeclared Drug Ingredients
ISSUE: Nano Well-being Health Inc. issued a voluntary recall of Super Arthgold, 500 mg capsules to the consumer level. FDA laboratory analysis has found the product to contain chlorzoxazone,...
FDA Approves Monovisc, a New Single Injection Treatment for Pain Due to Osteoarthritis of the Knee
BEDFORD, Mass., Feb. 25, 2014 --(BUSINESS WIRE)-- Anika Therapeutics, Inc. today announced it has received marketing approval for Monovisc from the U.S. Food and Drug Administration (FDA). Monovisc...
FDA Medwatch Alert: Reumofan Plus Dietary Supplement Relabeled and Sold as “WOW”: Public Warning - Undeclared Drug Ingredients
ISSUE: The U.S. Food and Drug Administration (FDA) is warning the public that the potentially harmful dietary supplement product Reumofan Plus is being relabeled and sold under the name “WOW.” The pr...
Horizon Pharma Announces FDA Approval of Duexis (Ibuprofen/Famotidine)
NORTHBROOK, IL--(Marketwire - Apr 25, 2011) - Horizon Pharma, Inc., a biopharmaceutical company developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis,...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related drug support groups
prednisone, Cymbalta, ibuprofen, naproxen, meloxicam, aspirin, duloxetine, diclofenac, methylprednisolone, view more... Celebrex, Aleve, Advil, Voltaren, triamcinolone, betamethasone, Medrol, Motrin, cortisone, Excedrin, indomethacin, Mobic, Arthritis Pain, glucosamine, nabumetone